Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-12-013311
Filing Date
2012-12-31
Accepted
2012-12-31 16:15:50
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cbc_10q-093012.htm 10-Q 546040
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 11779
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 11819
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 4563
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 6062
  Complete submission text file 0001437749-12-013311.txt   3691974

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE cbmc-20120930.xml EX-101.INS 630061
7 XBRL TAXONOMY EXTENSION SCHEMA cbmc-20120930.xsd EX-101.SCH 30629
8 XBRL TAXONOMY EXTENSION CALCULATION cbmc-20120930_cal.xml EX-101.CAL 25318
9 XBRL TAXONOMY EXTENSION DEFINITION cbmc-20120930_def.xml EX-101.DEF 157652
10 XBRL TAXONOMY EXTENSION LABELS cbmc-20120930_lab.xml EX-101.LAB 195257
11 XBRL TAXONOMY EXTENSION PRESENTATION cbmc-20120930_pre.xml EX-101.PRE 162168
Mailing Address 5000 HOPYARD ROAD, SUITE 480 PLEASANTON CA 94588
Business Address 5000 HOPYARD ROAD, SUITE 480 PLEASANTON CA 94588 9257307200
CALYPTE BIOMEDICAL CORP (Filer) CIK: 0000899426 (see all company filings)

EIN.: 061226727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32280 | Film No.: 121293701
SIC: 3826 Laboratory Analytical Instruments